Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 2

Conditions

Neoplasms 38Breast Neoplasms 31Lung Neoplasms 25Colorectal Neoplasms 15Prostatic Neoplasms 13Pancreatic Neoplasms 11Ovarian Neoplasms 11Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Sarcoma 8Colonic Neoplasms 8Uterine Cervical Neoplasms 7Melanoma 7Glioma 7Esophageal Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplastic Cells, Circulating 5Multiple Myeloma 5Endometrial Neoplasms 5Brain Neoplasms 5Neoplasm, Residual 4Gastrointestinal Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Renal Cell 4Adenocarcinoma 4Thrombosis 3Skin Neoplasms 3

Interventions

apixaban 3Blood Specimen Collection 3Enoxaparin 2Saline Solution 1Rivaroxaban 1Physical Therapy Modalities 1Musculoskeletal Manipulations 1Heparin, Low-Molecular-Weight 1Dexmedetomidine 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Thrombosis × Blood Specimen Collection × Clear all
NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Wake Forest University Health Sciences

Recruiting
35 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

NCT03830320 2026-02-27

Positron Emission Tomography (PET) Imaging of Thrombosis

Massachusetts General Hospital

Phase 1 Recruiting
165 enrolled

COVID-19, Atrial Fibrillation, Neoplasms, Thrombosis

NCT05839717 2024-12-17

CLOJAK

University Hospital, Bordeaux

Recruiting
120 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡